About a year ago, the first psychedelics-focused exchange-traded funds were debited on Toronto’s NEO exchange. The ETF, Horizons Psychedelic Stock Index (NEO: PSYK), was launched to focus on the relatively new industry. Less than six months after this launch, Defiance ETF launched the Defiance Next Gen Altered Experience in the U.S. Due to the low-key state of the industry then, both ETFs remained passive and focused on tracking a periodically restructured index. The only active ETF in the U.S. psychedelic sector is the AdvisorShares Psychedelics ETF, launched in September by AdvisorShares.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…